CQS Cayman’s Medicines Co MDCO Stock Holding History

CQS Cayman’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-100,000	Closed	-$2.77M	–	247
2014 Q4	$2.77M	Buy	+100,000	New	+$2.48M	0.18%	95

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CQS Cayman's MDCO Position: Q1 2015 in Review

CQS Cayman sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 100,000 shares — an estimated $2.77M sold.

CQS Cayman first reported a position in MDCO in Q4 2014 and held it in 1 quarter. The position peaked at $2.77M in Q4 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

CQS Cayman reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
CQS Cayman sold 100,000 Medicines Co shares in Q1 2015, an estimated $2.77M.
CQS Cayman first reported a position in Medicines Co in Q4 2014 and held it in 1 quarter.
CQS Cayman's Medicines Co position peaked at $2.77M in Q4 2014.
184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on CQS Cayman's 13F filing for Q1 2015, filed 13 May 2015.